{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:10:58Z","timestamp":1791724258999,"version":"4.3.4"},"reference-count":47,"publisher":"American Association for Cancer Research (AACR)","issue":"2","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Enhanced bone destruction is a hallmark of various carcinomas such as breast cancer, where osteolytic bone metastasis is associated with increased morbidity and mortality. Immune cells contribute to osteolysis in cancer growth, but the factors contributing to aggressive bone destruction are not well understood. In this study, we show the importance of myeloid-derived suppressor cells (MDSC) in this process at bone metastatic sites. Because MDSC originate from the same myeloid lineage as macrophages, which are osteoclast precursors, we hypothesized that MDSC may undergo osteoclast differentiation and contribute to enhanced bone destruction and tumor growth. Using an immunocompetent mouse model of breast cancer bone metastasis, we confirmed that MDSC isolated from the tumor-bone microenvironment differentiated into functional osteoclasts both in vitro and in vivo. Mechanistic investigations revealed that nitric oxide signaling was critical for differentiation of MDSC into osteoclasts. Remarkably, osteoclast differentiation did not occur in MDSC isolated from control or tumor-bearing mice that lacked bone metastasis, signifying the essential cross-talk between tumor cells and myeloid progenitors in the bone microenvironment as a requirement for osteoclast differentiation of MDSC. Overall, our results identify a wholly new facet to the multifunctionality of MDSC in driving tumor progression, in this case as a novel osteoclast progenitor that specifically drives bone metastasis during cancer progression. Cancer Res; 73(2); 672\u201382. \u00a92012 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-12-2202","type":"journal-article","created":{"date-parts":[[2012,12,15]],"date-time":"2012-12-15T21:16:15Z","timestamp":1355606175000},"page":"672-682","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":172,"title":["Myeloid-Derived Suppressor Cells Function as Novel Osteoclast Progenitors Enhancing Bone Loss in Breast Cancer"],"prefix":"10.1158","volume":"73","author":[{"given":"Anandi","family":"Sawant","sequence":"first","affiliation":[{"name":"Authors' Affiliations: Departments of 1Pathology and 2Medicine, The University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessy","family":"Deshane","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Pathology and 2Medicine, The University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Jules","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Pathology and 2Medicine, The University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carnella M.","family":"Lee","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Pathology and 2Medicine, The University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittney A.","family":"Harris","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Pathology and 2Medicine, The University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Feng","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Pathology and 2Medicine, The University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvarangan","family":"Ponnazhagan","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Pathology and 2Medicine, The University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2013,1,16]]},"reference":[{"key":"2022061703522830500_bib1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"2022061703522830500_bib2","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J Immunol"},{"key":"2022061703522830500_bib3","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/PPO.0b013e3181eb3358","article-title":"Myeloid-derived suppressor cells in human cancer","volume":"16","author":"Nagaraj","year":"2010","journal-title":"Cancer J"},{"key":"2022061703522830500_bib4","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00262-010-0855-8","article-title":"Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity","volume":"59","author":"Ostrand-Rosenberg","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"2022061703522830500_bib5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2141.2011.08678.x","article-title":"Myeloid-derived suppressor cells\u2013their role in haemato-oncological malignancies and other cancers and possible implications for therapy","volume":"153","author":"Tadmor","year":"2011","journal-title":"Br J Haematol"},{"key":"2022061703522830500_bib6","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00262-008-0609-z","article-title":"Adoptive transfer of HER2\/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells","volume":"58","author":"Morales","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"2022061703522830500_bib7","first-page":"3679","article-title":"Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells","volume":"47","author":"Young","year":"1987","journal-title":"Cancer Res"},{"key":"2022061703522830500_bib8","doi-asserted-by":"crossref","first-page":"11438","DOI":"10.1158\/0008-5472.CAN-07-1882","article-title":"Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor\u2013bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma","volume":"67","author":"Melani","year":"2007","journal-title":"Cancer Res"},{"key":"2022061703522830500_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"2022061703522830500_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/bjc.1987.225","article-title":"3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer","volume":"56","author":"Coleman","year":"1987","journal-title":"Br J Cancer"},{"key":"2022061703522830500_bib11","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N Engl J Med"},{"key":"2022061703522830500_bib12","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1073\/pnas.87.18.7260","article-title":"Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells","volume":"87","author":"Udagawa","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061703522830500_bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"2022061703522830500_bib14","doi-asserted-by":"crossref","first-page":"37427","DOI":"10.1074\/jbc.M110.149484","article-title":"Receptor activator of NF-{kappa}B (RANK) cytoplasmic IVVY535-538 motif plays an essential role in tumor necrosis factor-{alpha} (TNF)-mediated osteoclastogenesis","volume":"285","author":"Jules","year":"2010","journal-title":"J Biol Chem"},{"key":"2022061703522830500_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jneuroim.2010.03.011","article-title":"Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model","volume":"223","author":"Jia","year":"2010","journal-title":"J Neuroimmunol"},{"key":"2022061703522830500_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1083\/jcb.132.1.195","article-title":"Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype","volume":"132","author":"Erlebacher","year":"1996","journal-title":"J Cell Biol"},{"key":"2022061703522830500_bib17","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4049\/jimmunol.179.2.977","article-title":"Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response","volume":"179","author":"Sinha","year":"2007","journal-title":"J Immunol"},{"key":"2022061703522830500_bib18","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1158\/1078-0432.CCR-05-0883","article-title":"Gemcitabine selectively eliminates splenic Gr-1+\/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity","volume":"11","author":"Suzuki","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2022061703522830500_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/jbmr.5650020510","article-title":"Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2022061703522830500_bib20","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.freeradbiomed.2011.03.015","article-title":"Elevated levels of NO are localized to distal airways in asthma","volume":"50","author":"Anderson","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"2022061703522830500_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/mi.2011.16","article-title":"Free radical-producing myeloid-derived regulatory cells: potent activators and suppressors of lung inflammation and airway hyperresponsiveness","volume":"4","author":"Deshane","year":"2011","journal-title":"Mucosal Immunol"},{"key":"2022061703522830500_bib22","doi-asserted-by":"crossref","first-page":"e25838","DOI":"10.1371\/journal.pone.0025838","article-title":"Genetic ablation of CD68 results in mice with increased bone and dysfunctional osteoclasts","volume":"6","author":"Ashley","year":"2011","journal-title":"Plos One"},{"key":"2022061703522830500_bib23","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3899\/jrheum.101223","article-title":"Plectranthus amboinicus attenuates inflammatory bone erosion in mice with collagen-induced arthritis by downregulation of RANKL-induced NFATc1 expression","volume":"38","author":"Hsu","year":"2011","journal-title":"J Rheumatol"},{"key":"2022061703522830500_bib24","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/eji.201040895","article-title":"The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity","volume":"40","author":"Youn","year":"2010","journal-title":"Eur J Immunol"},{"key":"2022061703522830500_bib25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.coi.2010.01.021","article-title":"Myeloid-derived suppressor cell heterogeneity and subset definition","volume":"22","author":"Peranzoni","year":"2010","journal-title":"Curr Opinion Immunol"},{"key":"2022061703522830500_bib26","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1084\/jem.20100587","article-title":"HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment","volume":"207","author":"Corzo","year":"2010","journal-title":"J Exp Med"},{"key":"2022061703522830500_bib27","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1074\/jbc.M308197200","article-title":"Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling","volume":"279","author":"Kasuno","year":"2004","journal-title":"J Biol Chem"},{"key":"2022061703522830500_bib28","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1158\/0008-5472.CAN-06-2355","article-title":"Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer","volume":"67","author":"Hiraga","year":"2007","journal-title":"Cancer Res"},{"key":"2022061703522830500_bib29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/path.2534","article-title":"Acute hypoxia and osteoclast activity: a balance between enhanced resorption and increased apoptosis","volume":"218","author":"Knowles","year":"2009","journal-title":"J Pathol"},{"key":"2022061703522830500_bib30","first-page":"4648","article-title":"Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4","volume":"24","author":"Knowles","year":"2010","journal-title":"Faseb J"},{"key":"2022061703522830500_bib31","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.1038\/sj.onc.1204972","article-title":"Cell density mediated pericellular hypoxia leads to induction of HIF-1alpha via nitric oxide and Ras\/MAP kinase mediated signaling pathways","volume":"20","author":"Sheta","year":"2001","journal-title":"Oncogene"},{"key":"2022061703522830500_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.niox.2009.04.002","article-title":"Nitric oxide enhances osteoclastogenesis possibly by mediating cell fusion","volume":"21","author":"Nilforoushan","year":"2009","journal-title":"Nitric Oxide"},{"key":"2022061703522830500_bib33","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1902\/jop.2011.100768","article-title":"iNOS-derived nitric oxide stimulates osteoclast activity and alveolar bone loss in ligature-induced periodontitis in rats","volume":"82","author":"Herrera","year":"2011","journal-title":"J Periodontol"},{"key":"2022061703522830500_bib34","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bone.2004.12.002","article-title":"Inducible nitric oxide synthase mediates bone development and P. gingivalis-induced alveolar bone loss","volume":"36","author":"Gyurko","year":"2005","journal-title":"Bone"},{"key":"2022061703522830500_bib35","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1242\/jcs.108.12.3649","article-title":"Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones","volume":"108","author":"Blavier","year":"1995","journal-title":"J Cell Sci"},{"key":"2022061703522830500_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1359\/jbmr.1998.13.1.59","article-title":"The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors","volume":"13","author":"Sato","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2022061703522830500_bib37","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1074\/jbc.M110.174920","article-title":"Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis","volume":"286","author":"Das","year":"2011","journal-title":"J Biol Chem"},{"key":"2022061703522830500_bib38","doi-asserted-by":"crossref","first-page":"46659","DOI":"10.1074\/jbc.M407952200","article-title":"Differential osteopontin expression in phenotypically distinct subclones of murine breast cancer cells mediates metastatic behavior","volume":"279","author":"Mi","year":"2004","journal-title":"J Biol Chem"},{"key":"2022061703522830500_bib39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canlet.2008.03.018","article-title":"The inflammatory chemokines CCL2 and CCL5 in breast cancer","volume":"267","author":"Soria","year":"2008","journal-title":"Cancer Lett"},{"key":"2022061703522830500_bib40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cellimm.2011.05.001","article-title":"CCL5 induces a pro-inflammatory profile in microglia in vitro","volume":"270","author":"Skuljec","year":"2011","journal-title":"Cell Immunol"},{"key":"2022061703522830500_bib41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2006.12.012","article-title":"CCL2\/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers","volume":"252","author":"Huang","year":"2007","journal-title":"Cancer Lett"},{"key":"2022061703522830500_bib42","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3816\/CBC.2008.n.019","article-title":"Phase II trial of gemcitabine\/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer","volume":"8","author":"Loesch","year":"2008","journal-title":"Clin Breast Cancer"},{"key":"2022061703522830500_bib43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12032-010-9793-8","article-title":"Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients","volume":"29","author":"Brito","year":"2012","journal-title":"Med Oncol"},{"key":"2022061703522830500_bib44","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4143\/crt.2011.43.4.217","article-title":"Gemcitabine plus platinum combination chemotherapy for elderly patients with advanced non-small cell lung cancer: a retrospective analysis","volume":"43","author":"Chun","year":"2011","journal-title":"Cancer Res Treat"},{"key":"2022061703522830500_bib45","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.intimp.2009.03.015","article-title":"Gemcitabine directly inhibits myeloid derived suppressor cells in BALB\/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice","volume":"9","author":"Le","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"2022061703522830500_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-642-21892-7_3","article-title":"Bisphosphonates: prevention of bone metastases in breast cancer","volume":"192","author":"Gnant","year":"2012","journal-title":"Recent Results Cancer Res"},{"key":"2022061703522830500_bib47","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/jnci\/djr399","article-title":"Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer","volume":"103","author":"Monsees","year":"2011","journal-title":"J Natl Cancer Inst"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/73\/2\/672\/2690096\/672.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/73\/2\/672\/2690096\/672.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T09:20:27Z","timestamp":1655457627000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/73\/2\/672\/584786\/Myeloid-Derived-Suppressor-Cells-Function-as-Novel"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,15]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,1,16]]},"published-print":{"date-parts":[[2013,1,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-12-2202","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22398200.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22398176.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22398182.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22398197.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22398185","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22398176","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22398179.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22398197","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22398191","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22398194","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22398182","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22398194.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6504998","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22398188","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6504998.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22398188.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22398179","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22398185.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22398200","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22398191.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,15]]}}}